Enteral Access Technologies develops medical devices for safer nasogastric tube placement, featuring DoubleCHEK.
Enteral Access Technologies has raised $659K in total funding. The most recent round was Seed. The last funding was announced in November 2025.
Enteral Access Technologies's investors include The Future Fund, British Design Fund.
Enteral Access Technologies is headquartered in Liverpool, United Kingdom.
Enteral Access Technologies develops medical devices for safer nasogastric tube placement, featuring DoubleCHEK.
Enteral Access Technologies is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Enteral Access Technologies — Funding & Investors." VCBacked, November 11, 2025, https://www.vcbacked.co/company/enteral-access-technologies. Accessed September 15, 2026.
VCBacked. (2025). Enteral Access Technologies — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/enteral-access-technologies
{{cite web |title=Enteral Access Technologies — Funding & Investors |url=https://www.vcbacked.co/company/enteral-access-technologies |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated